Emil D. Kakkis

2013

In 2013, Emil D. Kakkis earned a total compensation of $685.5K as President and Chief Executive Officer at Ultragenyx Pharmaceutical, a 71% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$140,910
Option Awards$218,873
Salary$306,034
Other$19,721
Total$685,538

Kakkis received $306K in salary, accounting for 45% of the total pay in 2013.

Kakkis also received $140.9K in non-equity incentive plan, $218.9K in option awards and $19.7K in other compensation.

Rankings

In 2013, Emil D. Kakkis' compensation ranked 8,222nd out of 12,286 executives tracked by ExecPay. In other words, Kakkis earned more than 33.1% of executives.

ClassificationRankingPercentile
All
8,222
out of 12,286
33rd
Division
Manufacturing
2,978
out of 4,612
35th
Major group
Chemicals And Allied Products
933
out of 1,466
36th
Industry group
Drugs
708
out of 1,160
39th
Industry
Pharmaceutical Preparations
556
out of 890
38th
Source: SEC filing on April 18, 2016.

Kakkis' colleagues

We found two more compensation records of executives who worked with Emil D. Kakkis at Ultragenyx Pharmaceutical in 2013.

2013

Shalini Sharp

Ultragenyx Pharmaceutical

Chief Financial Officer

2013

Thomas Kassberg

Ultragenyx Pharmaceutical

Senior Vice President and Chief Business Officer

News

You may also like